I am a LT shareholder and I would have to disagree with the...

I am a LT shareholder and I would have to disagree with the statement "nothing has changed fundamentally"

Not so long ago, we had 4 potentially game changing trial results to look forward to this year (3 of them huge).
Fast forward to now, of the 3 trial results, GvHD was not passed and most likely won't be, CHF failed primary end point (but did show improvement in an important endpoint of 60% in mortality rate), COVID ARDS for all intents and purposes indicates a fail.
We have one result remaining.

You must admit that our prospects don't look anywhere near as promising as they did even a week ago.

The one positive is the 60% improvement in mortality rate for CHF. I think this result is too significant to be ignored.
We will have to see how this one plays out.

I would also feel a lot more comfortable if our partner sicks around over the next few days to get us past that 30 day option.

Best wishes to All.